BioSpace News Archive

Dialysis Patient Citizens introduced Dialysis Plan Choice, a new online tool designed in collaboration with Consumers’ Checkbook for dialysis patients to quickly and easily compare their current Medicare Fee-For-Service plan with the options available to them through Medicare Advantage now that Open Enrollment is underway.

Respected local specialty pharmacy provider with nearly two decades of service in San Diego joins forces with AHF Pharmacy and its 56 specialty pharmacy sites in 15 states, D.C. and Puerto Rico

TECHLAB® Inc., a leader in infectious disease diagnostics, announced it has partnered with the New River Valley COVID-19 Task Force to cost-effectively expand future COVID-19 testing capacity.

New data to be presented at the American College of Rheumatology Convergence 2020 demonstrate that the efficacy, pharmacokinetics and overall safety of CT-P17, a proposed high concentration and citrate-free adalimumab biosimilar, is comparable to reference adalimumab in the treatment of rheumatoid arthritis patients.

Alex Trebek’s Brave Battle and The Recent Passing of Supreme Court Justice Ruth Bader Ginsburg and Rep. John Lewis, Lead to Increased Public Awareness of Pancreatic Cancer

X4 Pharmaceuticals, Inc. announced that, on October 30, 2020, the Compensation Committee of X4’s Board of Directors issued an inducement award to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan.

Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today reported its financial results for the third quarter ended September 30, 2020

CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its third quarter 2020 financial results on Tuesday, November 10, 2020, after the close of the U.S. financial markets.

Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that Ryan Spencer, Chief Executive Officer, will present at the Stifel 2020 Virtual Healthcare Conference on Monday, November 16, at 3:30 p. m. E.T.

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases including solid tumors, hematologic cancers and autoimmune disease, today announced the Company will release third quarter 2020 financial results after market close on Monday, November 9, 2020.